ClearScript Offers Innovative Medication Therapy Management Program to Employee He...( Landmark Study Cites 12-...),Health

Landmark Study Cites 12-to-1 Return on Investment

MINNEAPOLIS, March 21 /PRNewswire/ -- ClearScript today announced that it is introducing Medication Therapy Management (MTM) as a benefit option to employer health plans across the US. A landmark study published in the Journal of the American Pharmacists Association cites a 12-to-1 return on investment for patients receiving MTM services through improved health outcomes and lower total health care expenditures.

"We are pleased to move MTM from successful pilot stage to a fully-fledged service available directly to employers," said Mike Reinke, ClearScript President. "MTM meets an urgent need for employers and health plan managers who are scrambling to contain plan costs while optimizing employee health and satisfaction."

ClearScript will provide MTM services through a network of specially trained pharmacists who provide 1-on-1 consultations with patients struggling with chronic diseases such as diabetes, high cholesterol and hypertension. Together with the patients' physicians and other healthcare providers, MTM pharmacists help patients solve medication-related problems, adhere to drug regimens and achieve optimal health outcomes.

ClearScript's MTM service model was developed collaboratively by Fairview Health Services and the University of Minnesota College of Pharmacy. Study results are documented in the March, 2008 issue of the Journal of the American Pharmacists Association in an article entitled Clinical and Economic Outcomes of Medication Therapy Management Services: The Minnesota Experience (Isetts, et al. J Am Pharm Assoc. 2008;48(2):203-211). The article reports on the effects of face-to-face MTM services in 285 patients with multiple medical conditions and complex drug therapies compared against a similar group of 252 patients who did not receive MTM services. Patients receiving MTM services demonstrated significant improvement in drug therapy goals achieved, dru
'/>"/>